Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom ( DrugBank: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1
49	全身性エリテマトーデス	1

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03480529 (ClinicalTrials.gov)	March 1, 2018	21/3/2018	Monitoring the IMmUological TOXicity of Drugs	Monitoring the IMmUological TOXicity of Drugs	Arthritis;Systemic Lupus Erythematosus;Rheumatoid Arthritis;Capillary Leak Syndrome;Hepatitis	Drug: drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom	Groupe Hospitalier Pitie-Salpetriere	Institut National de la Santé Et de la Recherche Médicale, France	Completed	18 Years	N/A	All	662		France

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03480529 (ClinicalTrials.gov)	March 1, 2018	21/3/2018	Monitoring the IMmUological TOXicity of Drugs	Monitoring the IMmUological TOXicity of Drugs	Arthritis;Systemic Lupus Erythematosus;Rheumatoid Arthritis;Capillary Leak Syndrome;Hepatitis	Drug: drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom	Groupe Hospitalier Pitie-Salpetriere	Institut National de la Santé Et de la Recherche Médicale, France	Completed	18 Years	N/A	All	662		France